Highlights Orthocell Limited

Equities

OCC

AU000000OCC6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 10:43:11 16/01/2026 am IST			5-day change	1st Jan Change
1.000 ^AUD	-1.48%		-7.41%	-7.83%

16/01	Orthocell Finalizes Agreement With Biotechnology Company	MT
16/01	Orthocell finalises strategic investment in Marine Biomedica	RE

Highlights

16/01	Orthocell Finalizes Agreement With Biotechnology Company	MT
06/01	Orthocell posts A$3.2 million in revenue for quarter ended 31 December	RE
15/12	Orthocell Submits Application to the British Standards Institution for Approval for Commercial Distribution of Nerve Repair Product, Shares Up 3%	MT
15/12	Orthocell submits regulatory application for commercial distribution of Remplir	RE
10/12	Orthocell Sells Nerve Repair Product in Hong Kong	MT
20/11	Orthocell Limited Announces Adoption of Remplir by Australian Urologists	CI
20/11	Orthocell To Set Up Commercialization Advisory Board for Nerve Repair Product, Shares Up 7%	MT
05/11	Orthocell Appoints Second Distributor in Canada for Nerve Repair Product	MT
29/25/29	Orthocell Appoints MontsMed as Exclusive Distributor for Remplir in Hong Kong	MT
29/25/29	Orthocell Appoints MontsMed as Its Exclusive In-Country Distributor for Hong Kong	CI
20/25/20	Orthocell secures rights to high-value bone regeneration tech	RE
20/25/20	Orthocell Signs MoU with Biotechnology Company; Shares Up 3%	MT
10/25/10	Orthocell Ltd reports quarterly revenue of A$3.0 million	RE
03/25/03	Orthocell's September Quarter Revenue Meets Fiscal 2026 Expectations, Euroz Hartleys Says	MT
02/25/02	Orthocell Ltd says revenue of A$3.0 mln achieved for quarter ended 30 Sept	RE
30/25/30	Orthocell Appoints First Canadian Distributor for Nerve Repair Product Ahead of Official Launch; Shares Soar 13%	MT
16/25/16	Orthocell Limited Announces Nerve-Sparing Prostate Cancer Surgery	CI
29/25/29	Orthocell Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
29/25/29	Orthocell Posts Wider Fiscal 2025 Loss, Higher Revenue	MT
09/25/09	Orthocell Ltd records revenue of A$2.73 million for June quarter	RE
01/25/01	Orthocell Says June Quarter Revenue Sequentially Rises Almost 23%; Shares Jump 8%	MT
12/25/12	Orthocell Secures Hong Kong License for Nerve Repair Product; Shares Up 3%	MT
30/25/30	Orthocell Secures Green Light to Start Sales of Nerve Repair Collagen Wrap in Canada; Shares Surge 13%	MT
28/25/28	Orthocell Says Remplir Approved To Commence Sales	RE
23/25/23	Orthocell Appoints First US Distributors for Nerve Repair Product; Shares Rise 6%	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Orthocell Limited

Equities

OCC

AU000000OCC6

Advanced Medical Equipment & Technology

Highlights

Filters